Search Results - "Tiefenbacher, C P"

A rare case: first description of a patient with melioidosis presenting with pericardial effusion in Germany by M, Elsharabassy, J, Gummert, S, Zange, CP, Tiefenbacher

Get full text

Reduction of myocardial infarct size by fluvastatin by Tiefenbacher, C P, Kapitza, J, Dietz, V, Lee, C-H, Niroomand, F

“…Statins have a variety of cardioprotective properties following chronic treatment. In contrast, little is known about the acute effects. Reperfusion acutely…”
Get more information

Telmisartan improves absolute walking distance and endothelial function in patients with peripheral artery disease by Zankl, A. R, Ivandic, B, Andrassy, M, Volz, H. C, Krumsdorf, U, Blessing, E, Katus, H. A, Tiefenbacher, C. P

“…Background Peripheral artery disease (PAD) is associated with high cardiovascular mortality and a poor quality of life. The AT1-receptor blocker telmisartan…”
Get full text

Role of human GTP cyclohydrolase I and its regulatory protein in tetrahydrobiopterin metabolism by Gesierich, A, Niroomand, F, Tiefenbacher, C P

“…GTP cyclohydrolase I (GTPCH I) catalyzes the de novo biosynthesis of tetrahydrobiopterin (BH(4)), an essential cofactor of NO-synthase. The enzyme underlies…”
Get full text

Influence of alcohol consumption on restenosis rate after percutaneous transluminal coronary angioplasty and stent implantation by Niroomand, F, Hauer, O, Tiefenbacher, C P, Katus, H A, Kuebler, W

“…Objective: To disclose possible influences of alcoholic beverages on restenosis rate in men with coronary artery disease treated with percutaneous transluminal…”
Get full text

Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin by TIEFENBACHER, C. P, CHILIAN, W. M, MITCHELL, M, DEFILY, D. V

“…A deficit in the endothelial production of nitric oxide (NO) is associated with the sequelae of reperfusion injury. Because endothelial NO synthesis depends on…”
Get full text

Expression of nitric oxide related enzymes in coronary heart disease by Chen, X, Niroomand, F, Liu, Z, Zankl, A, Katus, H A, Jahn, L, Tiefenbacher, C P

“…Enzymes involved in the metabolism nitric oxide (NO) and reactive oxygen species (ROS) may play a role for the decreased availability of NO in atherosclerosis…”
Get full text

99mTcO(BAT-NI), a novel nitroimidazole tracer: in vivo uptake studies in ischaemic myocardium by HOFTEND, J, LINKER, G, MOHAMMED, A, TIEFENBACHER, C. P, EISENHUT, M, HABERKORN, U

“…Myocardial perfusion single-photon emission tomography (SPET) performed with cationic technetium-99m complexes indicates ischaemic areas as cold lesions. By…”
Get full text

Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation by TIEFENBACHER, C. P, CHILIAN, W. M

“…The strong angiogenic and mitogenic agents acidic and basic fibroblast growth factors (aFGF and bFGF, respectively) share signalling pathways with known…”
Get full text

Heterogeneity of coronary vasomotion by Tiefenbacher, C P, Chilian, W M

“…Apart from local heterogeneities of myocardial blood flow, the regulation of vascular tone is equally complex. Changes in vascular tone are essential for the…”
Get full text

Pathology, natural history and treatment of abdominal aortic aneurysms by Zankl, A R, Schumacher, H, Krumsdorf, U, Katus, H A, Jahn, L, Tiefenbacher, C P

“…With increasing age of the population and improvement of diagnostic tools, the incidence of abdominal aortic aneurysms (AAA) has been rising steadily. Despite…”
Get full text

ROCKET AF by Tiefenbacher, C P

“…Prevention of thromboembolic events, especially ischemic strokes, is a priority in the management of patients with atrial fibrillation. This is done either by…”
Get full text

Adaptation of myocardial blood flow to increased metabolic demand is not dependent on endothelial vasodilators in the rat heart by Tiefenbacher, C. P., Tillmanns, H., Niroomand, F., Zimmermann, R., Kübler, W.

“…OBJECTIVE: To investigate the role of endothelial vasodilating factors in adaptation of myocardial blood flow to increased metabolic demands. DESIGN:…”
Get full text

Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? by Tiefenbacher, C P

Get more information

Endothelial dysfunction of coronary resistance arteries is improved by tetrahydrobiopterin in atherosclerosis by TIEFENBACHER, Christiane P, BLEEKE, Tina, VAHL, Christian, AMANN, Kerstin, VOGT, Achim, KÜBLER, Wolfgang

“…Tetrahydrobiopterin (BH4), an essential cofactor for the synthesis of NO, improves endothelial dysfunction after ischemia/reperfusion. Therefore, we…”
Get full text

Inhibition of elastase improves myocardial function after repetitive ischaemia and myocardial infarction in the rat heart by Tiefenbacher, C P, Ebert, M, Niroomand, F, Batkai, S, Tillmanns, H, Zimmermann, R, Kübler, W

“…We investigated the potential of inhibition of elastase, a granulocyte-derived proteolytic enzyme, in ameliorating the effects of myocardial stunning caused by…”
Get full text

Endothelin plasma levels in acute graft rejection after heart transplantation by Dengler, T J, Zimmermann, R, Tiefenbacher, C P, Braun, K, Sack, F U, Kübler, W

“…Endothelin is an oligopeptide of endothelial origin with potent vasoconstrictive and mitogenic properties, implicated in the pathogenesis of…”
Get more information

Preservation of myocardial blood flow by calcium antagonists does not prevent attenuation of regional myocardial function after repetitive brief periods of myocardial ischaemia in the rat heart by Tiefenbacher, C P, Zimmermann, R, Parekh, N, Amann, K, Tillmanns, H, Rauch, B, Kübler, W

“…The aim of this study was to assess the effect of two different calcium channel blockers on myocardial blood flow and function in a rat model of myocardial…”
Get more information

Impaired renal function but not high cyclosporine levels determines increased endothelin plasma levels after heart transplantation by Dengler, T J, Tiefenbacher, C P, Braun, K, Sack, F U, Zimmermann, R, Kübler, W

Get more information

Nitric oxide-mediated endothelial dysfunction--is there need to treat? by Tiefenbacher, C P, Kreuzer, J

“…Before it gets to the development of manifest atherosclerotic lesions, all known risk factors primarily induce functional alterations in the vascular wall,…”
Get more information